Opportunities and challenges of protein-based targeted protein degradation

• Published in: Chemical science (Cambridge) 2023-08, Vol.14 (32), p.8433-8447
• Main Authors: Shen, Fangfang, Dassama, Laura M. K
• Format: Article
• Language: English
• Subjects: Antibodies; Binding; Chemistry; Degradation; Nucleic acids; Platforms; Proteins
• ISSN: 2041-6520; 2041-6539
• DOI: 10.1039/d3sc02361c

In the 20 years since the first report of a proteolysis targeting chimeric (PROTAC) molecule, targeted protein degradation (TPD) technologies have attempted to revolutionize the fields of chemical biology and biomedicine by providing exciting research opportunities and potential therapeutics. However, they primarily focus on the use of small molecules to recruit the ubiquitin proteasome system to mediate target protein degradation. This then limits protein targets to cytosolic domains with accessible and suitable small molecule binding pockets. In recent years, biologics such as proteins and nucleic acids have instead been used as binders for targeting proteins, thereby expanding the scope of TPD platforms to include secreted proteins, transmembrane proteins, and soluble but highly disordered intracellular proteins. This perspective summarizes the recent TPD platforms that utilize nanobodies, antibodies, and other proteins as binding moieties to deplete challenging targets, either through the ubiquitin proteasome system or the lysosomal degradation pathway. Importantly, the perspective also highlights opportunities and remaining challenges of current protein-based TPD technologies. Targeted protein degradation strategies employing proteins as binders for degradation targets.